Today we’re announcing two exciting editorial hires at Endpoints News: Karen Weintraub + Kevin Miller. Karen Weintraub is our new deputy editor and will help oversee our coverage of biotech, science and medicine, managing a team …
The latest in Epic’s fight over patient health data
Epic last week scored a win in a lawsuit that revolves around who has a right to patient health data. On Friday, the electronic health record giant managed to get defendant GuardDog Telehealth to admit …
Warlock Ransomware Group Augments Post-Exploitation Activities
In a recent attack, the group showcased stealthier cross-network activity, thanks to its use of a new BYOVD technique and other tools.
Pfizer’s next-gen breast cancer data; Bristol Myers’ PRMT5 candidate
Plus, news about Genentech, Mestag and BioVie: 📊 Pfizer says next-gen breast cancer drug succeeds in Phase 2: The company is developing a CDK4 inhibitor called atirmociclib as a successor to its breast cancer drug …
Rhythm’s Imcivree fails Phase 3 rare form obesity trial
Rhythm Pharmaceuticals’ Imcivree has hit a snag on the way to a major approval deadline. The biotech’s MC4R agonist failed to significantly reduce weight in a Phase 3 trial that enrolled patients with rare, genetically …
Fierce Madness: Get your picks in for the 1st round of the 2026 Drug Name Tournament
It’s time once again for Fierce Pharma Marketing’s annual #FierceMadness tournament. This time around, we’re watching 64 newly minted drug names go head to head.
Bicycle to cut 30% of staff after cancer drug’s regulatory setback
Bicycle Therapeutics plans to cut its operating expenses in half to preserve cash, laying off about 30% of its staff and ending work on two early trials, the company announced. Bicycle made the moves after …
Inside Olympic Cybersecurity: Lessons From Paris 2024 to Milan Cortina 2026
Discover how Franz Regul, former CISO for the Paris 2024 Olympics, tackled unique cybersecurity challenges to protect the Olympics from evolving threats.
Hologic finds women’s health stagnating over five years of global surveys
In its fifth year, the annual Hologic Global Women’s Health Index found only minimal improvements in preventive screening rates from the first report, and no change at all in an overall analysis of women’s health around the world.
Meningitis outbreak in UK prompts call to widen vaccination
A UK patient group is calling for changes to the decade-old meningitis vaccination programme, after an outbreak in Kent killed two young people.
Roche, Nvidia to build largest ‘AI factory’ in pharma
Just a few weeks ago, Eli Lilly executives cut the ribbon of what they called pharma’s most powerful supercomputer. On Monday, Roche shared plans to steal that title. The Swiss drugmaker announced …
New renal disease biotech R1 Therapeutics nabs $77.5M for Phase 2b
A fresh renal disease biotech expects to be on the market with a new hyperphosphatemia medicine for dialysis patients by the end of this decade, and it might still be a private company when it …